Shares of CRISPR Therapeutics CRSP were up 3.7% yesterday after the company announced encouraging updates from ongoing studies on its next-generation CAR-T therapy candidate, zugocaptagene geleucel or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback